Bionoid Pharma Total Current Liabilities

Bionoid Pharma posts a total current liabilities of $150K as of June 2025. That compares with $160K in the prior-year period — down 5.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bionoid Pharma's total current liabilities was $160K. The latest reading is $150K — a 5.1% year-over-year decrease (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Bionoid Pharma's financial statement story. At $150K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BINP's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bionoid Pharma's other metric pages and overview cover the third.